Shailendra K. Saxena – författare

This book provides a comprehensive overview of the different water-associated infectious diseases and their linked pathogens with plausible strategies for their mitigation. Although, we are in the era of 21st century having most of the advanced technologies at hand, yet water-associated infectious diseases are the major contributors towards the worldwide morbidity and mortality. The book also focuses on the various implementation strategies of sustainable hygienic conditions, discusses the robust, and reliable policies and strategies on a global aspect to provide unprivileged people access to the basic sanitation, hygiene and water. In addition, the book discusses the possible indirect effect of global warming on the spread of infectious diseases through the distribution of associated vectors.

This book provides a comprehensive overview of recent novel coronavirus (SARS-CoV-2) infection, their biology and associated challenges for their treatment and prevention of novel Coronavirus Disease 2019 (COVID-19). Discussing various aspects of COVID-19 infection, including global epidemiology, genome organization, immunopathogenesis, transmission cycle, diagnosis, treatment, prevention, and control strategies, it highlights host-pathogen interactions, host immune response, and pathogen immune invasion strategies toward developing an immune intervention or preventive vaccine for COVID-19.

An understanding of the topics covered in the book is imperative in the context of designing strategies to protect the human race from further losses and harm due to SARS-CoV-2 infection causing COVID-19.

The book examines the role of artificial intelligence during the COVID-19 pandemic, including its application in i) early warnings and alerts, ii) tracking and prediction, iii) data dashboards, iv) diagnosis and prognosis, v) treatments, and cures, and vi) social control. It explores the use of artificial intelligence in the context of population screening and assessing infection risks, and presents mathematical models for epidemic prediction of COVID-19. Furthermore, the book discusses artificial intelligence-mediated diagnosis, and how machine learning can help in the development of drugs to treat the disease. Lastly, it analyzes various artificial intelligence-based models to improve the critical care of COVID-19 patients.

This book provides a comprehensive overview of the recent trends in various Nanotechnology-based therapeutics and challenges associated with its development. Nanobiotechnology is an interdisciplinary research that has wide applications in the various fields of biomedical research. The book discusses the various facets of the application of Nanotechnology in drug delivery, clinical diagnostics, Nanomedicine and treatment of infectious and chronic diseases. The book also highlights the recent advancements on important devices and applications that are based on Nanotechnology in medicine and brief the regulatory and ethical issues related to nanomedical devices. It also reviews the toxicological profile of various nanomaterials and emphasizes the need for safe nanomaterials for clinical use. Finally, the book discusses the recent developments of potential commercial applications of Nanotechnology.

The book explores the intersection of AI, telehealth, and viral infections, discussing the role of AI in pandemics, telehealth services, viral diagnosis, and antiviral drug development. It explores the integration of AI into telehealth, predicting outbreaks and monitoring mutations. The book emphasizes patient-centric healthcare, highlighting AI''s transformative potential in infectious diseases. It covers medical virology, bioinformatics, machine learning, and neural networks. AI enables streamlined workflows, improved patient care, and new research methodologies. It addresses challenges and tailored solutions for AI integration in telehealth.

It serves as a valuable resource for clinicians, physicians, virologists, researchers, and healthcare professionals seeking to navigate the evolving landscape of telehealth and harness the full potential of AI in transforming healthcare delivery.

This book provides a comprehensive overview of Japanese Encephalitis (JE), its pathobiology, and associated challenges for treatment and prevention. It focuses on various aspects of Japanese Encephalitis, including global epidemiology, genome organization and genotypes, virus-host interactions, immunopathogenesis, transmission dynamics, antibody-dependent enhancement, clinical characteristics, laboratory diagnosis, treatment, prevention, and control strategies. It provides a brief account of the Japanese encephalitis vaccine, their immunogenicity, protective ability, and impact of JE’s vaccine in reducing the burden of the disease. It also helps in understanding the molecular and cellular factors involved in the JE virus neuro-invasion and inflammatory processes. The book uniquely presents cutting-edge information and provides an edited information source for clinicians, virologists, pathologists, and immunologists.